Abstract:Acyl-CoA Oxidase-1 (ACOX1) deficiency (MIM 264470) is an autosomal recessive disease characterized by impairments in the desaturation of acyl-CoAs to 2-trans-enoyl-CoAs, which is the first step in the catalysis of the β-oxidative breakdown of very long chain fatty acids (VLCFA) occuring in peroxisomes. The deleterious accumulation of VLCFA in several organs, including the brain, is a key biochemical feature of this disease which has devastating neurological consequences. ACOX1 deficiency is ultra-rare; as such, few studies have been conducted to determine the leading causes of symptoms or uncover new therapeutics. When confronted with one such case, we decided to bring drug discovery tools to the patient's bedside in an attempt to identify a cure. A skin biopsy was performed on a young patient with ACOX1 deficiency, following which screening technologies and mass spectrometry analysis techniques were applied to design a cellular assay that enabled the direct measurement of the effect of small molecules on the patient's primary fibroblasts. This approach is particularly well adapted to inherited metabolic disorders such as ACOX1 deficiency. Through the evaluation of a proprietary library of repurposable drugs, we found that the anthelmintic drug niclosamide led to a significant reduction in VLCFA in vitro. This drug was subsequently administered to the patient for more than six years. This study outlines the screening and drug selection processes. Additionally, we present our comprehensive clinical and biochemical findings that aided in understanding the patient's natural history and analysis of the progression of the patient's symptoms throughout the treatment period. Although the patient's overall lifespan was extended compared to the average age at death in severe early onset cases of ACOX1 deficiency, we did not observe any definitive evidence of clinical or biochemical improvement during niclosamide treatment. Nonetheless, our study shows a good safety profile of long-term niclosamide administration in a child with a rare neurodegenerative disease, and illustrates the potential of individualized therapeutic strategies in the management of inherited metabolic disorders, which could benefit both patients and the broader scientific and medical communities.

Peroxisomal acyl-CoA oxidase deficiency: one case report and literature review

A case of multiple carboxylase deficiency presenting with skin lesions as the initial symptom induced by a novel mutation in the holocarboxylase synthetase gene

[Analysis of GFM1 Gene Mutations in a Family with Combined Oxidative Phosphorylation Deficiency 1].

ACOX2 Deficiency in Primary Malignant Cardiac Tumors

Novel Heterozygous Compound TRMT5 Mutations Associated with Combined Oxidative Phosphorylation Deficiency 26 in a Chinese Family: a Case Report

Ataxia with novel compound heterozygous PEX10 mutations and a literature review of PEX10-related peroxisome biogenesis disorders.

Findings from the individualized management of a patient with Acyl-CoA Oxidase-1 (ACOX1) deficiency: A bedside-to-bench-to-bedside strategy

A novel case of ACOX2 deficiency leads to recognition of a third human peroxisomal acyl-CoA oxidase

Novel ACADVL Variants Resulting in Mitochondrial Defects in Long-Chain Acyl-Coa Dehydrogenase Deficiency.

Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency in Chinese Patients: Eight Case Reports, Including One Case of Prenatal Diagnosis

A new case of malonyl-CoA decarboxylase deficiency with mild clinical features.

A Novel Homozygous ACBD5 Variant in an Emerging Peroxisomal Disorder Presenting with Retinal Dystrophy and a Review of the Literature

ACOX2 deficiency: A disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment

Clinical characteristics and genetic analysis of 2 children with pyridox (am)ine-5'-phosphate oxidase deficiency

Adult-onset combined oxidative phosphorylation deficiency type 14 manifests as epileptic status: a new phenotype and literature review

Clinical and genetic analysis of a case with atypical ethyl malonate encephalopathy

Early Onset of Combined Oxidative Phosphorylation Deficiency in Two Chinese Brothers Caused by a Homozygous (Leu275Phe) Mutation in the <i>C1QBP</i> Gene

Clinical and genetic analysis of combined oxidative phosphorylation defificiency-10 caused by MTO1 mutation

ACOX1 gain‐of‐function variation in a 10‐years‐old patient responsive to immunomodulating therapy

A New Genetic Disorder in Mitochondrial Fatty Acid β-Oxidation: ACAD9 Deficiency

One Potential Hotspot ACADVL Mutation in Chinese Patients with Very-Long-chain Acyl-Coenzyme A Dehydrogenase Deficiency.